SUMF1 (Gene)

Synonyms:AAPA3037, ENTREZ:100130207, ENTREZ:285362, FGE, HGNC:20376, LOC100130207, MIM:607939, NM_001164674, NM_001164675, NM_182760, NP_001158146, NP_001158147, NP_877437, NR_149025, SUMF1, UNQ3037, XM_011533624, XM_011533625, XM_011533626, XM_017006252, XM_017006253, XM_017006254, XM_017006255, XP_011531926, XP_011531927, XP_011531928, XP_016861741, XP_016861742, XP_016861743, XP_016861744, sulfatase modifying factor 1, uncharacterized LOC100130207
Omim:OMIM:607939
Id:ENSG00000144455
Hgnc:HGNC:20376
Entrez:285362
Description:sulfatase modifying factor 1
This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View SUMF1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with SUMF1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using SUMF1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for SUMF1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SUMF1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.